Three suspects were arrested in Pennsylvania after attempting to steal $16,000 worth of injectable weight-loss drugs, including Ozempic, Mounjaro, and Trulicity, from a pharmacy delivery.
On January 15, 2026, three individuals were arrested in Bensalem Township, Pennsylvania, following the attempted theft of high-value prescription weight-loss medications from a delivery driver outside a local pharmacy. According to police reports, the suspects assaulted the driver during a routine delivery and stole two boxes containing injectable medications, including Mounjaro, Ozempic and Trulicity valued at approximately USD 16,000. Law enforcement recovered the stolen drugs shortly after the incident and reported no serious injuries to the driver.2
The incident occurred at around 9:00 a.m. outside Smart Choice Pharmacy on Street Road in Bensalem, a suburban area near Philadelphia. Police identified the suspects as two adults aged 41 and 21, along with a 17-year-old minor. Authorities stopped the suspects’ vehicle roughly two miles from the pharmacy within minutes of the robbery and placed all three individuals under arrest. They now face multiple charges, including robbery, theft, assault, and conspiracy.
The stolen shipment reportedly included injectable glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide- and tirzepatide-based therapies. These medications are approved for the management of type 2 diabetes and, in specific formulations, for chronic weight management. GLP-1 receptor agonists work by enhancing insulin secretion, delaying gastric emptying, and reducing appetite, which contributes to weight loss and improved metabolic control.1
These drugs are costly, with monthly prices often exceeding USD 1,000 for uninsured patients. Their high market value and limited availability have increased the risk of theft and diversion from legitimate supply chains.
Investigators reported that the suspects appeared to have prior knowledge of the delivery schedule. Pharmacy staff disclosed that they had received unusual phone calls and emails in the days preceding the incident, requesting specific information about medication shipments. Authorities believe this communication may have been used to plan the theft. Surveillance and witness accounts suggest the suspects waited in the parking area before confronting the delivery driver.
The theft highlights growing security challenges associated with high-demand prescription medications. Increased public awareness and demand for weight-loss therapies have strained supply chains and raised concerns about illegal resale. Diversion of prescription medications poses risks to patient safety, as improperly stored or counterfeit products may enter unregulated markets. Health authorities emphasize that GLP-1 receptor agonists should only be dispensed through licensed pharmacies and used under medical supervision.1
1. Food and Drug Administration (FDA). 2023. FDA Approves New Indications for GLP-1 Receptor Agonists. U.S. Food and Drug Administration.
(Rh/SS/MSM)